University of Miami, Miami Veteran Administration Hospital, Miami, FL, USA.
J Gastrointestin Liver Dis. 2009 Sep;18(3):359-61.
An increased incidence of non-Hodgkin's lymphoma has been reported in patients with inflammatory bowel disease, particularly in those receiving immunosuppressive therapy. Rare cases of Hodgkin;s lymphoma have been reported in a setting of inflammatory bowel disease. The mechanism underlying the apparent association is unclear, but alterations in immune surveillance could play a role. In this report we describe the clinicopathological features of primary gastrointestinal Hodgkin's lymphoma diagnosed in a patient with Crohn's ileocolitis who had been receiving therapy with immunomodulator and biologic therapies.
据报道,炎症性肠病患者中非霍奇金淋巴瘤的发病率增加,特别是在接受免疫抑制治疗的患者中。在炎症性肠病的背景下,也有罕见的霍奇金淋巴瘤病例报告。潜在关联的机制尚不清楚,但免疫监视的改变可能起作用。在本报告中,我们描述了一位接受免疫调节剂和生物治疗的克罗恩病回结肠患者中诊断的原发性胃肠道霍奇金淋巴瘤的临床病理特征。